Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Prospective studies on insulin-like growth factor I (IGF-I) and epithelial ovarian cancer (EOC) risk are inconclusive. Data suggest risk associations vary by tumour characteristics. METHODS: We conducted a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC) to evaluate IGF-I concentrations and EOC risk by tumour characteristics (n=565 cases). Multivariable conditional logistic regression models were used to estimate associations. RESULTS: We observed no association between IGF-I and EOC overall or by tumour characteristics. CONCLUSIONS: In the largest prospective study to date was no association between IGF-I and EOC risk. Pre-diagnostic serum IGF-I concentrations may not influence EOC risk.

Original publication

DOI

10.1038/bjc.2014.566

Type

Journal article

Journal

Br J Cancer

Publication Date

06/01/2015

Volume

112

Pages

162 - 166

Keywords

Adult, Aged, Case-Control Studies, Cohort Studies, Europe, Female, Humans, Insulin-Like Growth Factor I, Middle Aged, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Prospective Studies, Risk